Rizkallah, M. R.; Saad, R.; Aziz, R. K. (2010). "The Human Microbiome Project, Personalized Medicine and the Birth of Pharmacomicrobiomics". Current Pharmacogenomics and Personalized Medicine. 8 (3): 12. doi:10.2174/187569210792246326.
Egert, M; De Graaf, AA; Smidt, H; De Vos, WM; Venema (2006). "Functional microbiomics of the human colon". Trends Microbiol. 14 (2): 86–91. doi:10.1016/j.tim.2005.12.007. PMID16406528.
Sousa, T; Paterson, R; Moore, V; Carlsson, A; Abrahamsson, B; Basit, AW (2008). "The gastrointestinal microbiota as a site for the biotransformation of drugs". Int J Pharm. 363 (1–2): 1–25. doi:10.1016/j.ijpharm.2008.07.009. PMID18682282.
Lennernäs, H; Abrahamsson, B (2005). "The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension". J Pharm Pharmacol. 57 (3): 273–285. doi:10.1211/0022357055263. PMID15807982. S2CID45646857.
R. Rizkallah, Mariam; Gamal-Eldin, Soha; Saad, Rama; Aziz, Ramy K. (2012). "The PharmacoMicrobiomics Portal: A Database for Drug-Microbiome Interactions". Current Pharmacogenomics and Personalized Medicine. 10 (3): 195–203. doi:10.2174/187569212802510030.
Rumney, CJ; Rowland, IR (1992). "In vivo and in vitro models of the human colonic flora". Crit Rev Food Sci Nutr. 31 (4): 299–331. doi:10.1080/10408399209527575. PMID1581008.
Marsh, PD (1995). "The role of continuous culture in modelling the human microflora". J Chem Technol Biotechnol. 64 (1): 1–9. doi:10.1002/jctb.280640102.
Vermes, A; Kuijper, EJ; Guchelaar, HJ; Dankert, J (2003). "An in vitro study on the active conversion of flucytosine to fluorouracil by microorganisms in the human intestinal microflora". Chemotherapy. 49 (1–2): 17–23. doi:10.1159/000069784. PMID12714804. S2CID27515058.
Egert, M; De Graaf, AA; Smidt, H; De Vos, WM; Venema (2006). "Functional microbiomics of the human colon". Trends Microbiol. 14 (2): 86–91. doi:10.1016/j.tim.2005.12.007. PMID16406528.
Sousa, T; Paterson, R; Moore, V; Carlsson, A; Abrahamsson, B; Basit, AW (2008). "The gastrointestinal microbiota as a site for the biotransformation of drugs". Int J Pharm. 363 (1–2): 1–25. doi:10.1016/j.ijpharm.2008.07.009. PMID18682282.
Lennernäs, H; Abrahamsson, B (2005). "The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension". J Pharm Pharmacol. 57 (3): 273–285. doi:10.1211/0022357055263. PMID15807982. S2CID45646857.
Rumney, CJ; Rowland, IR (1992). "In vivo and in vitro models of the human colonic flora". Crit Rev Food Sci Nutr. 31 (4): 299–331. doi:10.1080/10408399209527575. PMID1581008.
Vermes, A; Kuijper, EJ; Guchelaar, HJ; Dankert, J (2003). "An in vitro study on the active conversion of flucytosine to fluorouracil by microorganisms in the human intestinal microflora". Chemotherapy. 49 (1–2): 17–23. doi:10.1159/000069784. PMID12714804. S2CID27515058.
Lennernäs, H; Abrahamsson, B (2005). "The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension". J Pharm Pharmacol. 57 (3): 273–285. doi:10.1211/0022357055263. PMID15807982. S2CID45646857.
Vermes, A; Kuijper, EJ; Guchelaar, HJ; Dankert, J (2003). "An in vitro study on the active conversion of flucytosine to fluorouracil by microorganisms in the human intestinal microflora". Chemotherapy. 49 (1–2): 17–23. doi:10.1159/000069784. PMID12714804. S2CID27515058.
ucsc.edu
rna.ucsc.edu
"Ribosome Images". Center for Molecular Biology of RNA. Archived from the original on 2023-06-08. Retrieved 2024-07-12.